Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

    Catharina Margrethe Lerche, Hans Christian Wulf
    e13
    14-09-2010
    https://doi.org/10.4081/dr.2010.e13
    2147
    PDF: 853
    HTML: 175
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2686
    PDF: 982
    HTML: 31
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2393
    PDF: 1409
    HTML: 106
  • Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

    Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    19-05-2023
    https://doi.org/10.4081/dr.2023.9692
    1057
    PDF: 546
    HTML: 19
  • Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

    Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin
    12-09-2023
    https://doi.org/10.4081/dr.2023.9773
    916
    PDF: 464
    HTML: 18
  • Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

    Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    12-11-2024
    https://doi.org/10.4081/dr.2024.10080
    1172
    PDF: 659
    HTML: 27
  • Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)

    Luca Fania, Cesare Massone, Francesco Cusano, Fabrizio Fantini, Elena Dellambra, Tonia Samela, Francesca Passarelli, Roberto Morese, Tommaso Tartaglione, Marino Maggiore, Piercarlo Gentile, Mattia Falchetto Osti, Francesca Sampogna, Sabatino Pallotta, Damiano Abeni, Paolo Marchetti, Luigi Naldi, ADOI steering group*
    05-08-2021
    https://doi.org/10.4081/dr.2021.9278
    3094
    PDF: 799
    HTML: 36
  • Effects of canary seed on two patients with disseminated granuloma annulare

    Lily Park, Claudia Green, Sergey Arutyunyan, Gabriella Vasile, Christopher Buckley, Eduardo Weiss
    23-12-2022
    https://doi.org/10.4081/dr.2023.9614
    1569
    PDF: 478
    HTML: 508
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    662
    PDF: 381
    HTML: 16
  • Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

    Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole
    19-06-2023
    https://doi.org/10.4081/dr.2023.9755
    851
    PDF: 415
    HTML: 17
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    406
    PDF: 273
    HTML: 11
  • New and emerging therapies in cutaneous T-cell lymphoma

    Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino
    02-10-2024
    https://doi.org/10.4081/dr.2024.10002
    1086
    PDF: 589
    HTML: 94
  • Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

    Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash
    29-01-2025
    https://doi.org/10.4081/dr.2025.10257
    635
    PDF: 369
    SUPPLEMENTARY MATERIAL: 49
    HTML: 5
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1081
    PDF: 717
    HTML: 57
  • Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

    Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris
    03-02-2026
    https://doi.org/10.4081/dr.2026.10644
    532
    PDF: 301
  • Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

    Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota
    11-11-2024
    https://doi.org/10.4081/dr.2024.10140
    989
    PDF: 521
    SUPPLEMENTARY MATERIAL: 153
    HTML: 16
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1306
    PDF: 405
    HTML: 45
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1162
    PDF: 825
    HTML: 41
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1686
    PDF: 679
    HTML: 85
  • Telangiectasia Macularis Eruptiva Perstans: more than skin deep

    Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy
    e12
    29-07-2011
    https://doi.org/10.4081/dr.2011.e12
    11687
    PDF: 2218
    HTML: 2302
  • A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

    Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang
    12-04-2024
    https://doi.org/10.4081/dr.2024.9899
    965
    PDF: 564
    HTML: 25
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    441
    PDF: 304
    HTML: 7
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1377
    PDF: 661
    HTML: 142
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    251
    PDF: 154
  • Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study

    Simone Amato, Annunziata Dattola, Luigi Bennardo, Martina Tolone, Steven Paul Nisticò
    08-07-2025
    https://doi.org/10.4081/dr.2025.10333
    385
    PDF: 240
    HTML: 0
1 - 25 of 34 items 1 2 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy